Skip to main content
SpringerLink
Log in

Adalimumab

Spondylodiscitis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Conforti C, et al. Adalimumab-associated spondylodiscitis: A new or underestimated side effect?. Dermatologic Therapy 33: e13468, No. 4, 28 Apr 2020. Available from: URL: http://doi.org/10.1111/dth.13468

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1826, 18 (2020). https://doi.org/10.1007/s40278-020-84465-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-84465-8

Search

Navigation